Tumor Necrosis Factor Inhibitors and Janus Kinase Inhibitors in the Treatment of Cicatricial Alopecia: A Systematic Review

    February 2024 in “ PloS one ”
    Nima Hajizadeh, Amirhossein Heidari, Sara Sadeghi, Azadeh Goodarzi
    Studysummary This review concluded that oral tofacitinib and adalimumab are promising treatments for cicatricial alopecia, showing effectiveness in improving signs and symptoms but requiring regular monitoring for adverse effects. The authors emphasize the need for further extensive studies to solidify these findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.plos.org →
    Discuss this study in the Community →

    Research cited in this study 20

    1. Various Applications of Tofacitinib and Ruxolitinib in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective Dermatology practical & conceptual · 2022
    2. The Efficacy and Safety of JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis of Prospective Studies Frontiers in pharmacology · 2022
    3. Refractory Folliculitis Decalvans Treated With Adalimumab: A Case Series of 23 Patients Journal of the American Academy of Dermatology · 2022
    4. Discoid Lupus Erythematosus of the Scalp in a Patient with Systemic Lupus Erythematosus: A Case Report with Complete Hair Regrowth Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2021
    5. The role of biologic treatment in special scenarios in hidradenitis suppurativa: Facial and nape phenotype, dissecting cellulitis of the scalp, and lymphedema Dermatologic Therapy · 2021
    6. Folliculitis Decalvans Responsive to Tofacitinib: A Case Series Dermatologic Therapy · 2020
    7. Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible Skin appendage disorders · 2020
    8. The Role of Janus Kinase Inhibitors in the Treatment of Alopecia Areata: A Systematic Review Dermatologic therapy · 2019
    9. JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2019
    10. Tofacitinib for the Treatment of Lichen Planopilaris: A Case Series Dermatologic therapy · 2018
    11. Efficacy of Oral Tofacitinib in the Treatment of Lichen Planopilaris ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 2018
    12. Cicatricial Alopecia: Overview and Treatment Recommendations Journal der Deutschen Dermatologischen Gesellschaft · 2018
    13. Emerging Drugs for Alopecia Areata: JAK Inhibitors Expert opinion on emerging drugs · 2018
    14. Clinical Investigation of JAK Inhibitor Tofacitinib in Scarring Alopecias Journal of Investigative Dermatology · 2017
    15. JAK Inhibitors in Dermatology: The Promise of a New Drug Class Journal of the American Academy of Dermatology · 2017
    16. Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement After Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies Dermatology and therapy · 2016
    17. Treatment Options for Alopecia Expert Opinion on Pharmacotherapy · 2015
    18. Management of Primary Cicatricial Alopecias: Options for Treatment British Journal of Dermatology · 2008
    19. Onset of Lichen Planopilaris During Treatment with Etanercept British Journal of Dermatology · 2008
    20. Lichen Planopilaris Treated With Thalidomide Journal of the American Academy of Dermatology · 2001